Stocks Health care BPTH
OTC · Health careBio-Path Holdings, Inc. (BPTH)
It posted a net loss of $9.9M. At March 31, 2026 it held $12K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 20, 2026.
Watch BPTH in 60 secondsWhat Bio-Path Holdings, Inc. does
Bio-Path Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BPTH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | n/a | -$9.9M | -$4.12 | n/a |
| 2023 | n/a | -$16.1M | -$33.63 | n/a |
| 2022 | n/a | -$13.9M | -$38.12 | -$15.1M |
| 2021 | n/a | -$10.4M | -$30.94 | -$10M |
| 2020 | n/a | -$10.9M | -$56.48 | n/a |
| 2019 | n/a | -$8.6M | -$64.66 | -$8.4M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Bio-Path Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 20, 2026Form 1-SA filing 1-SA
- August 5, 2026Form 253G2 filing 253G2
- July 16, 2026
- May 26, 2026
- May 22, 2026Deregistration 15-12G
- May 20, 2026
- May 15, 2026Late quarterly report notice NT 10-Q
- May 1, 2026Form 1-K filing 1-K
- April 28, 2026Form QUALIF filing QUALIF
- March 25, 2026Form 1-A filing 1-A
Questions about BPTH
What does Bio-Path Holdings, Inc. do?
Bio-Path Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BPTH.
Is Bio-Path Holdings, Inc. profitable?
No. In fiscal 2024 it reported a net loss of $9.9M.
When did Bio-Path Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 20, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the form 1-SA filing from August 20, 2026.
Similar companies
Compare BPTH with
Follow BPTH
Get an email when Bio-Path Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BPTH: get an email when it filesWhere the numbers come from
Financial figures are the values Bio-Path Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.